The goal of this research is to further study the priming of macrophages produced by inescapable tail shock (IS). To this end, the first part of the grant will identify the physiological signal which primes macrophages during IS. Macrophage priming occurs in response to a stressor, therefore norepinephrine and corticosterone, chemical mediators elevated during stress, will be examined. The endogenous source of these mediators will be removed and replaced to evaluate their respective roles in macrophage pruning. As result of macrophage priming T-cell proliferation in response to antigen is suppressed. Studies in vitro indicate that the signal suppressing T-cell proliferation is released from the primed macrophage. Therefore, the aim of the second part of the grant will be to determine the suppressive signal. Activated macrophages release several mediators which can suppress T-cell proliferation. These include nitric oxide (NO), reactive oxygen species (ROS) and prostaglandin E2 (PGE2). The experiments proposed in the second part of the grant involve administering the antigen keyhole limpet hemocyanin (KLH), and then manipulating the availability of NO, ROS or PGE2 and evaluating T-cell proliferation. This research will provide a greater understanding of the relationship between stress and the immune response.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI051093-01
Application #
6405982
Study Section
Special Emphasis Panel (ZRG1-IFCN-2 (01))
Program Officer
Prograis, Lawrence J
Project Start
2001-02-28
Project End
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
1
Fiscal Year
2001
Total Cost
$33,260
Indirect Cost
Name
University of Colorado at Boulder
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
City
Boulder
State
CO
Country
United States
Zip Code
80309
Wieseler-Frank, Julie; Maier, Steven F; Watkins, Linda R (2005) Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun 19:104-11
Milligan, Erin D; Langer, Stephen J; Sloane, Evan M et al. (2005) Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 21:2136-48
Wieseler-Frank, Julie; Maier, Steven F; Watkins, Linda R (2005) Central proinflammatory cytokines and pain enhancement. Neurosignals 14:166-74
Johnston, Ian N; Milligan, Erin D; Wieseler-Frank, Julie et al. (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24:7353-65
Holguin, Adelina; O'Connor, Kevin A; Biedenkapp, Joseph et al. (2004) HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain 110:517-30
Wieseler-Frank, Julie; Maier, Steven F; Watkins, Linda R (2004) Glial activation and pathological pain. Neurochem Int 45:389-95
Chacur, Marucia; Gutierrez, Jose Maria; Milligan, Erin D et al. (2004) Snake venom components enhance pain upon subcutaneous injection: an initial examination of spinal cord mediators. Pain 111:65-76
Chacur, Marucia; Milligan, Erin D; Sloan, Evan M et al. (2004) Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide. Pain 108:180-91
Spataro, Leah E; Sloane, Evan M; Milligan, Erin D et al. (2004) Spinal gap junctions: potential involvement in pain facilitation. J Pain 5:392-405